van Maurik, A., Herber, M., Wood, K., & Jones, N. (2002). Cutting edge: CD4+CD25+ alloantigen-specific immunoregulatory cells that can prevent CD8+ T cell-mediated graft rejection: implications for anti-CD154 immunotherapy.
Chicago-referens (17:e uppl.)van Maurik, A., M. Herber, K. Wood, och N. Jones. Cutting Edge: CD4+CD25+ Alloantigen-specific Immunoregulatory Cells That Can Prevent CD8+ T Cell-mediated Graft Rejection: Implications for Anti-CD154 Immunotherapy. 2002.
MLA-referens (9:e uppl.)van Maurik, A., et al. Cutting Edge: CD4+CD25+ Alloantigen-specific Immunoregulatory Cells That Can Prevent CD8+ T Cell-mediated Graft Rejection: Implications for Anti-CD154 Immunotherapy. 2002.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.